{| {{table}}
| align="center" style="background:#f0f0f0;"|'''Long-term outcome of permanent urethral stents in the treatment of detrusor-sphincter dyssynergia'''| align="center" style="background:#f0f0f0;"|'''To evaluate the long-term efficacy of a permanently implanted urethral stent in the treatment of spinally injured patients with detrusor-sphincter dyssynergia.'''| align="center" style="background:#f0f0f0;"|'''13'''| align="center" style="background:#f0f0f0;"|'''Detrusor-sphincter dyssynergia'''| align="center" style="background:#f0f0f0;"|'''Stenting is an effective alternative to sphincterotomy in the long-term, although secondary bladder neck obstruction is a frequent problem.'''|-| Nephrostomy Tube or \'JJ\' Ureteric Stent in Ureteric Obstruction: Assessment of Patient Perspectives Using Quality-of-Life Survey and Utility Analysis||Upper urinary tract obstruction is often relieved by either a percutaneous nephrostomy tube (PCN) or a ureteric stent. Both can cause considerable morbidity and reduce patient\'s health-related quality of life (QoL). We have compared the QoL in these 2 groups.||34||Upper urinary tract obstruction||\" Patients with \'JJ\' stents have significantly more irritative urinary symptoms and a high chance of local discomfort than patients with nephrostomy tubes (PCN). However, based on the EuroQol analysis, there is no significant difference in the gross impact on the health-related QoL or the utility between these groups indicating no patient preference for either modality of treatment.|-| \"|-| Impact of stents on urological complications and health care expenditure in renal transplant recipients: results of a prospective, randomized clinical trial.||A randomized, prospective trial to compare the incidence of early urological complications and health care expenditures in renal transplant recipients with or without ureteral stenting.||201||Renal transplant recipient||Using a ureteral stent at renal transplantation significantly decreases the early urinary complications of urine leakage and obstruction. However, there is a significant increase in urinary tract infections, primarily beyond 30 days after transplantation. Stent removal within 4 weeks of insertion appears advisable.|-| |} {| {{table}}| align="center" style="background:#f0f0f0;"|'''Title'''| align="center" style="background:#f0f0f0;"|'''Abstract'''| align="center" style="background:#f0f0f0;"|'''Enrollment'''| align="center" style="background:#f0f0f0;"|'''Disorder'''| align="center" style="background:#f0f0f0;"|'''Conclusion'''
|-
| Long-term outcome of permanent urethral stents in the treatment of detrusor-sphincter dyssynergia ||To evaluate the long-term efficacy of a permanently implanted urethral stent in the treatment of spinally injured patients with detrusor-sphincter dyssynergia.||13||Detrusor-sphincter dyssynergia||Stenting is an effective alternative to sphincterotomy in the long-term, although secondary bladder neck obstruction is a frequent problem.